6 курс / Кардиология / Джон_Кэмм_Болезни_сердца_и_сосудов_2011
.pdfBogaty P., Dagenais G.R., Cantin B. et al. Prognosis in patients with a strongly positive exercise electrocardiogram // Am. J. Cardiol. - 1989. - Vol. 64. - P. 1284-1288.
Hung J., Chaitman B.R., Lam. J., et al. Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy // J. Am. Coll. Cardiol. - 1994. - Vol. 4. - P. 8-16.
Gupta N.C., Esterbrooks D.J., Hilleman D.E. et al. Comparison of adenosine and exercise thallium201. single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group // J. Am. Coll. Cardiol. - 1992. - Vol. 19. - P. 248-257.
Nishimura S., Mahmarian J.J., Boyce T.M. et al. Equivalence between adenosine and exercise thallium201. myocardial tomography: a multicenter, prospective, crossover trial // J. Am. Coll. Cardiol. - 1992. - Vol. 20. - P. 265-275.
The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) (1997). ACC/AHA Guidelines for the Clinical Application of Echocardiography // Circulation. - 1997. - Vol. 95. - P. 1686-1744.
Dagianti A., Penco M., Agati L. et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease // J. Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 18-25.
Nagel E., Lehmkuhl H.B., Bocksch W. et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography // Circulation. - 1999. - Vol. 99. - P. 763-770.
Hundley W.G., Morgan T.M., Neagle C.M. et al. Magnetic resonance imaging determination of cardiac prognosis // Circulation. - 2002. - Vol. 106. - P. 2328-2333.
Schwitter J., Nanz D., Kneifel S. et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography // Circulation. - 2001. - Vol. 103. - P. 2230-2235.
Agatston A.S., Janowitz W.R., Hildner F.J. et al. Quantification of coronary artery calcium using ultrafast computed tomography // J. Am. Coll. Cardiol. - 1990. - Vol. 15. - P. 827-832.
Rumberger J.A., Simons D.B., Fitzpatrick L.A. et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study // Circulation. - 1995. - Vol. 92. - P. 2157-2162.
Miller J.M., Rochitte C.E., Dewey M. et al. Diagnostic Performance of Coronary Angiography by 64-Row CT // N. Engl. J. Med. - 2008. - Vol. 359. - P. 2324-2336.
Pennell D.J., Sechtem U.P., Higgins C.B. et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report // Eur. Heart J. - 2004. - Vol. 25. - P. 1940-1965.
Toussaint J.F., LaMuraglia G.M., Southern J.F. et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo // Circulation. - 1996. -
Vol. 94. - P. 932-938.
Mintz G.S., Nissen S.E., Anderson W.D. et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents // J. Am. Coll. Cardiol. - 2001. - Vol. 37. - P. 1478-1492.
Gould K.L., Kirkeeide R.L., Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity // J. Am. Coll. Cardiol. - 1990. - Vol. 15. - P. 459-474.
Di Carli M., Czernin J., Hoh C.K. et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease // Circulation. - 1995. - Vol. 91. - P. 1944-1951.
Pijls N.H., De Bruyne B., Peels K. et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses // N. Engl. J. Med. - 1996. - Vol. 334. - P. 1703-1708.
Hubbard B.L., Gibbons R.J., Lapeyre A.C 3rd et al. Identification of severe coronary artery disease using simple clinical parameters // Arch. Intern. Med. - 1992. - Vol. 152. - P. 309-312.
Harris P.J., Harrell F.E., Lee K.L. et al. Survival in medically treated coronary artery disease // Circulation. - 1979. - Vol. 60. - P. 1259-1269.
Califf R.M., Armstrong P.W., Carver J.R. et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5: stratification of patients
into high, medium and low risk subgroups for purposes of risk factor management // J. Am. Coll. Cardiol. - 1996. - Vol. 27. - P. 1007-1019.
Daly C.A., De Stavola B., Lopez Sendon J.L. et al. Predicting prognosis in stable angina results from the Euro heart survey of stable angina: prospective observational study // BMJ. - 2006. - Vol. 332. - P. 262267.
Emond M., Mock M.B., Davis K.B. et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry // Circulation. - 1994. - Vol. 90. - P. 2645-2657.
Weiner D.A., Ryan T.J., McCabe C.H. et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease // J. Am. Coll. Cardiol. - 1984. - Vol. 3. - P. 772779.
Weiner D.A., Ryan T.J., McCabe C.H. et al. Value of exercise testing in determining the risk classification and the response to coronary artery bypass grafting in 3-vessel coronary artery disease: a report from the Coronary Artery Surgery Study (CASS) registry // Am. J. Cardiol. - 1987. - Vol. 60. - P. 262-6.
Mark D.B., Shaw L., Harrell F.E., Jr. et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease // N. Engl. J. Med. - 1991. - Vol. 325. - P. 849-853.
Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 521-547.
Kotler T.S., Diamond G.A. Exercise thallium-201. scintigraphy in the diagnosis and prognosis of coronary artery disease // Ann. Intern. Med. - 1990. - Vol. 113. - P. 684-702.
Marcovitz P.A., Shayna V., Horn R.A. Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease // Am. J. Cardiol. - 1996. -
Vol. 78. - P. 404-408.
Rocco M.B., Nabel E.G., Campbell S. et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease // Circulation. - 1988. - Vol. 78. - P. 877-884.
Crea F, Lanza G.A. The elusive link between stenosis severity and prognosis in stable ischaemic heart disease // Heart. - 2003. - Vol. 89. - P. 961-962.
Bigi R., Cortigiani L., Colombo P. et al. Prognostic and clinical correlates of angiographically diffuse nonobstructive coronary lesions // Heart. - 2003. - Vol. 89. - P. 1009-1013.
Mark D.B., Nelson C.L., Califf R.M. et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty // Circulation. - 1994. - Vol. 89. - P. 2015-2025.
20th Bethesda Conference. Insurability and employability of the patient with ischemic heart disease. October 3-4, 1988 // J. Am. Coll. Cardiol. - 1989. - Vol. 14. - P. 1004-1044.
Haustein K.O. What can we do in secondary prevention of cigarette smoking? // Eur. J. Cardiovasc. Prev. Rehabil. - 2003. - Vol. 10. - P. 476-485.
US Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Available at: http:// surgeongeneral.gov/library/smokingconsequences/ Washington, DC. - 2004.
Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease. An update // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1731-1737.
Hung J., Lam J.Y., Lacoste L. et al. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin // Circulation. - 1995. - Vol. 92. - P. 2432-2436.
US Department of Health and Human Services. The Health Benefits of Smoking Cessation. Washington, DC: US Department of Health and Human Services. - 1990.
Tzivoni D., Keren A., Meyler S. et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking // Cardiovasc. Drugs Ther. - 1998. - Vol. 12. - P. 239244.
Eisenberg M.J., Filion K.B., Yavin D. et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials // CMAJ. - 2008. - Vol. 179. - P. 135-144.
Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3. fatty acids, and cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. - 2003. - Vol. 23: e20-e30.
Mead A., Atkinson G., Albin D. et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease evidence from systematic reviews of randomized controlled trials (second update, January 2006) // J. Hum. Nutr. Diet. - 2006. - Vol. 19. - P. 401-419.
Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: executive summary // Eur .Heart J. - 2007. - Vol. 28. - P. 2375-2414.
GISSI Prevenzione Investigators. Dietary supplementation with n-3. polyunsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-Prevenzione trial. Gruppo Italiano per lo
Studio della Sopravivvenza nell’Infarto miocardico // Lancet. - 1999. - Vol. 54. - P. 447-455.
Hooper L., Thompson R.L., Harrison R.A. et al. Risks and benefits of omega 3. fats for mortality, cardiovascular disease, and cancer: systematic review // BMJ. - 2006. - Vol. 332. - P. 752-760.
Rejeski W., Brawley L.R., Ambrosius W.T. et al. Older adults with chronic disease: benefits of groupmediated counseling in the promotion of physically active lifestyles // Health Physiol. - 2003. - Vol. 22. - P. 414-423.
Hammermeister K.E., DeRouen T.A., Dodge H.T. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations // Circulation. - 1979. - Vol. 59. -
P. 421-430.
Taylor R.S., Brown A., Ebrahim S. et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials // Am. J. Med. - 2004. - Vol. 116. - P. 682-692.
Shaw K., O’Rourke P., Del Mar C. et al. Psychological interventions for overweight or obesity // Cochrane Database Syst. Rev. - 2005. - Vol. 2: CD003818.
Wing R., Tate D.F., Gorin A.A. et al. A self-regulation program for maintenance of weight loss // N Engl. J. Med. - 2006. - Vol. 355. - P. 1563-1571.
Fox K.M., Thadani U., Ma P.T. et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina // Eur. Heart J. - 2003. - Vol. 24. - P. 2206-2212.
Arruda-Olson A.M., Mahoney D.W., Nehra A. et al. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease // JAMA. - 2002. - Vol. 287. - P. 719-725.
Baigent C., Keech A., Kearney P.M. et al. Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056. participants in 14. randomised trials of statins // Lancet. - 2005. - Vol. 366. - P. 1267-1278.
Cannon C.P., Braunwald E., McCabe C.H. et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes // N. Engl. J. Med. - 2004. - Vol. 350. - P. 495-504.
Gotto A.M., Amarenco P, Assman G., et al. Dyslipedemia and Coronary Heart Disease, 3rd edn, 2003. New York: International Lipid Information Bureau.
Josan K., Majumdar S.R., McAlister F.A. The efficacy and safety of intensive statin therapy: a metaanalysis of randomized trials //CMAJ. - 2008. - Vol. 178. - P. 576-584.
Rubins H.B., Robins S.J., Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of highdensity lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group // N. Engl. J. Med. - 1999. - Vol. 341. - P. 410-418.
The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. The Bezafibrate Infarction Prevention (BIP) Study // Circulation. - 2000. - Vol. 102. - P. 21-27.
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963. people with diabetes: a randomised controlled trial // Lancet. - 2003. - Vol. 361. - P. 2005-2006.
Luscher T.F., Creager M.A., Beckman J.A. et al. Diabetes and vascular disease // Circulation. - 2003. - Vol. 108. - P. 1655-1661.
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61. prospective studies // Lancet. - 2002. -
Vol. 360. - P. 1903-1913.
Patrono C., Coller B., FitzGerald G.A. et al. Platelet-active // Drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy // Chest. - 2004. - Vol. 126. - P. 234S-264S.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients // Br. Med. J. - 2002. - Vol. 324. - P. 71-86.
The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Guidelines on the management of stable angina pectoris: executive summary // Eur. Heart J. - 2006. - Vol. 27. - P. 1341-1381.
Juul-Möller S., Edvardsson N., Jahnmatz B. et al. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group // Lancet. - 1992. - Vol. 340. - P. 1421-1425.
Sudlow C., Baigent C. The adverse effects of different doses of aspirin: a systematic review of randomised trials and observational studies (Abstract) // Stroke. - 2000. - Vol. 31. - P. 2869.
Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding // BMJ. - 1995. - Vol. 310. - P. 827-830.
Chan F.K., Ching J.Y., Hung L.C. et al. Clopidogrel vs. aspirin and esomeprazole to prevent recurrent ulcer bleeding // N. Engl. J. Med. - 2005. - Vol. 352. - P. 238-244.
Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs // J. Thromb. Haemost. - 2003. - Vol. 1. - P. 1710-1713.
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) // Lancet. - 1996. - Vol. 348. - P. 1329-1339.
Saw J., Brennan D.M., Steinhubl S.R. et al. - CHARISMA Investigators. Lack of evidence of a clopidogrelstatin interaction in the CHARISMA trial // J. Am. Coll. Cardiol. - 2007. - Vol. 50. - P. 291-295.
Andreotti F., Testa L., Biondi-Zoccai G.G. et al. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307. patients // Eur. Heart J. - 2006. - Vol. 27. - P. 519-526.
Karjalainen P.P., Porela P., Ylitalo A. et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting // Eur. Heart J. - 2007. - Vol. 28. - P. 726-732.
Yusuf S., Wittes J., Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction // JAMA. - 1988. - Vol. 260. - P. 2088-2093.
Freemantle N., Cleland J., Young P. et al. Blockade after myocardial infarction: systematic review of meta regression analysis // Br. Med. J. - 1999. - Vol. 318. - P. 1730-1737.
Rehnqvist N., Hjemdahl P., Billing E. et al. Effects of metoprolol vs. verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) // Eur. Heart J. - 1996. - Vol. 17. - P. 76-81.
Dargie H.J., Ford I., Fox K.M. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group // Eur. Heart J. - 1996. - Vol. 17. - P. 104-112.
Pepine C.J, Cohn PF, Deedwania PC, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) // Circulation. - 1994. - Vol. 90. - P. 762-768.
Brophy J.M., Joseph L., Rouleau J.L. Beta-blockers in congestive heart failure. A Bayesian meta-analysis // Ann. Intern. Med. - 2001. - Vol. 134. - P. 550-560.
The Danish Verapamil Infarction Trial II-DAVIT II Effect of verapamil on mortality and major events after acute myocardial infarction // Am. J. Cardiol. - 1990. - Vol. 66. - P. 779-785.
Pepine C.J., Hanberg E.M., Cooper-DeHoff R.M. et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease // JAMA. - 2003. - Vol. 290. - P. 2805-2860.
The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction // N. Engl. J. Med. - 1988. - Vol. 319. - P. 385-392.
Boden W.E., Gilst W.H., Scheldewaert RG, et al. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial // Lancet. - 2000. - Vol. 335. - P. 1751-1756.
Poole-Wilson P.A., Lubsen J., Kirwan B.A. et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial // Lancet. - 2004. - Vol. 364. - P. 849-857.
Nissen S.E., Tuzcu E.M., Libby P. et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial // JAMA. - 2004. - Vol. 292. - P. 2217-2225.
Rosenson, R.S. Modulating atherosclerosis through inhibition or blockade of angiotensin // Clin. Cardiol. - 2003. - Vol. 26. - P. 305-311.
Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients // N. Engl. J. Med. - 2000. - Vol. 342. -
P. 145-153.
European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) // Lancet. - 2003. - Vol. 362. - P. 782-788.
Braunwald E., Domanski M.J., Fowler S.E. et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The PEACE trial investigators // N. Engl. J. Med. - 2004. - Vol. 351. - P. 20582117.
ONTARGET Investigators, Yusuf S., Teo K.K., Pogue J,. et al. Telmisartan, ramipril, or both in patients at high risk for vascular events // N. Engl. J. Med. - 2008. - Vol. 358. - P. 1547-1559.
Parker JO. Nitrate tolerance // Eur. J. Clin. Pharmacol. - 1990. - Vol. 38: S21-S25.
Thadani U. Medical therapy of stable angina pectoris // Cardiol. Clin. - 1991. - Vol. 9. - P. 73-87. Thadani U. Treatment of stable angina // Curr. Opin. Cardiol. - 1999. - Vol. 14. - P. 349-358.
Bakris G.L., Fonseca V., Katholi R.E. et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2. diabetes mellitus and hypertension // JAMA. - 2004. - Vol. 292. - P. 2227-2236.
Hjemdahl P., Wiklund I.K. Quality of life on antihypertensive drug therapy scientific end-point or marketing exercise? // J. Hypertens. - 1992. - Vol. 10. - P. 1437-1446.
Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) ACC/AHA 2002. guideline update for the management of patients with chronic stable anginasummary article: a report of the American College of Cardiology/American Heart Association // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 159-168.
Savonitto S., Ardissino D. Selection of drug therapy in stable angina pectoris // Cardiovasc. Drugs Ther. - 1998. - Vol. 12. - P. 197-210.
Deanfield J.E., Detry J.M., Lichtlen P.R. et al. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial) // J. Am. Coll. Cardiol. - 1994. - Vol. 24. - P. 1460-1467.
Ardissino D., Savonitto S., Egstrup K. et al. Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 1516-1521.
Forslund L., Hjemdahl P., Held C. et al. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS) // Eur. Heart J. - 2000. - Vol. 21. - P. 901-910.
Arnim T.V. Medical treatment to reduce total ischaemic burden: total ischaemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators // J. Am. Coll. Cardiol. - 1995. - Vol. 25. - P. 231-238.
Fox K.M., Mulcahy D., Findlay I. et al. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608. patients with stable angina. The TIBET Study Group // Eur. Heart J. - 1996. - Vol. 17. - P. 96-103.
Heidenreich P.A., McDonald K.M., Hastie T. et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina // JAMA. - 1999. - Vol. 281. - P. 1927-1936.
Markham A., Plosker G.L., Goa K.L. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects // Drugs. - 2000. - Vol. 60. - P. 955-974.
The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial // Lancet. - 2002. - Vol. 359. - P. 1269-1275.
Fox K., Ford I., Steg P.G. et al. - BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial // Lancet. - 2008. - Vol. 372. - P. 817-821.
Singh, B.N. Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate // J. Cardiovasc. Pharmacol. Ther. - 2001. - Vol. 6. - P. 313-331.
Borer J.S., Fox K., Jaillon P.G. et al., for the Ivabradine Investigators Group. Anti-anginal and antiischaemic effects of ivabradine, an I(f)inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial // Circulation. - 2003. - Vol. 107. - P. 817-823.
Tardif J.C., Ponikowski P., Kahan T. et al. - ASSOCIATE Study Investigators. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial // Eur. Heart. J. - 2009. - Vol. 30. - P. 540-548.
O’Rourke, R.A. Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFox inhibitor // Curr. Probl. Cardiol. - 2002. - Vol. 27. - P. 521556.
Chaitman B.R., Skettino S.L., Parker J.O. for the Monotherapy Assesment of Ranolazine in Stable Angina (MARISA) Investigators. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with severe chronic angina // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1375-1382.
Chaitman B.R., Pepine C.J., Parker J.O., for the Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem or exercise tolerance and angina frequency in patients with severe chronic angina. A randomized controlled trial // JAMA. - 2004. - Vol. 291. - P. 309-316.
Stone P.H., Gratsiansky N.A., Blokhin A. et al. - ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial // J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 566-575.
Wilson S.R., Scirica B.M., Braunwald E. et al. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36. Trial // J. Am. Coll. Cardiol. - 2009. - Vol. 53. - P. 1510-1516.
Juni P., Nartey L., Reichenbach S. et al. Risk of cardiovascular events and rofecoxib: cumulative metaanalysis // Lancet. - 2004. - Vol. 364. - P. 2021-2029.
Kearney P.M., Baigent C., Godwin J. et al. Do selective cyclo-oxygenase-2. inhibitors and traditional nonsteroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials // BMJ. - 2006. - Vol. 332. - P. 1302-1308.
Rossouw J.E., Prentice R.L., Manson J.E. et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause // JAMA. - 2007. - Vol. 297. - P. 1465-1477.
Grüntzig A. Transluminal dilatation of coronary-artery stenosis // Lancet. - 1978. - Vol. 1. - P. 263.
Lenzen M.J., Boersma E., Mertrand M.E., et al. Management and outcome of patients with significant coronary artery disease: the EuroHeart Survey on coronary revascularisation // Eur. Heart J. - 2005. - Vol. 26. - P. 1169-1179.
Violaris A.G., Serruys P.W. New technologies in interventional cardiology // Curr. Opin. Cardiol. - 1994. - Vol. 9. - P. 493-502.
Hall P., Nakamura S., Maiello L. et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation // Circulation. - 1996. - Vol. 93. - P. 215-222.
Brophy J.M., Belisle P., Joseph L. Evidence for use of coronary stents. A hierarchical bayesian metaanalysis // Ann. Intern. Med. - 2003. - Vol. 138. - P. 777-786.
Al Suwaidi J., Holmes D.R. Jr., Salam A.M., et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty // Am. Heart J. - 2004. - Vol. 147. - P. 815-822.
Kastrati A. Schömig A., Elezi S. et al. Predictive factors of restenosis after coronary stent placement // J. Am. Coll. Cardiol. - 1997. - Vol. 30. - P. 1428-1436.
Mehran R., Dangas G., Abizaid A.S. et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome // Circulation. - 1999. - Vol. 100. - P. 1872-1878.
Waksman R., Ajani A.E., White R.L. et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis // Circulation. - 2004. - Vol. 109. - P. 340-344.
Babapulle M.N., Joseph L., Belisle P. et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents // Lancet. - 2004. - Vol. 364. - P. 583-591.
Barbato E., Marco J., Wijns W. Direct stenting // Eur. Heart J. - 2003. - Vol. 24. - P. 394-403.
Schofer J., Schlüter M., Gershlick A.H. et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) // Lancet. - 2003. - Vol. 362. - P. 1093-1099.
Lemos P.A., Serruys P.W., Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the ‘real world’: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry // Circulation. - 2004. - Vol. 109. - P. 190-195.
Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions // Eur. Heart J. - 2005. - Vol. 26. - P. 804-847.
Stone G.W., Ellis S.G., Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation // Circulation. - 2007. - Vol. 115. - P. 2842-2847.
James S.K., Stenestrand U., Lindbäck J. et al. Long-term safety and efficacy of drug-eluting versus baremetal stents in Sweden // N. Engl. J. Med. - 2009. - Vol. 360. - P. 1933-1945.
Patti G., Colonna G., Pasceri V. et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2. (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study // Circulation. - 2005. - Vol. 111. - P. 2099-2106.
Kastrati A., Mehilli J., Schühlen H. et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel // N. Engl. J. Med. - 2004. - Vol. 350. - P. 232-238.
Montalescot G., White H.D., Gallo R. et al. - STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention // N. Engl. J. Med. - 2006. - Vol. 355. - P. 10061017.
Mahaffey K.W., Lewis B.E., Wildermann N.M. et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results // J. Invasive Cardiol. - 2003. - Vol. 15. - P. 611-616.
Parisi A.F., Folland E.D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators // N. Engl. J. Med. - 1992. - Vol. 326. - P. 10-16.
RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial // Lancet. - 1997. - Vol. 350. - P. 461-468.
Pitt B., Waters D., Brown W.V. et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators // N. Engl. J. Med. - 1999. - Vol. 341. - P. 70-76.
Katritsis D.G., Ioannidis J.P. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis // Circulation. - 2005. - Vol. 111. - P. 2906-2912.
Boden W.E., O’Rourke R.A., Teo K.K. et al. - COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease // N. Engl. J. Med. - 2007. - Vol. 356. - P. 1503-1516.
Schömig A., Mehilli J., de Waha A. et al. A meta-analysis of 17. randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease // J. Am. Coll. Cardiol. - 2008. - Vol. 52. - P. 894-904.
Bech G.J., Bruyne B., Bonnier H.J. et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 841-847.
Favaloro R.G. Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique // J. Thorac. Cardiovasc. Surg. - 1969. - Vol. 58. - P. 178-185.
Barner H.B., Standeven J.W., Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass // J. Thorac. Cardiovasc. Surg. - 1985. - Vol. 90. - P. 668-675.
Cameron A., Davis K.B., Green G. et al. Coronary bypass surgery with internal-thoracic-artery graftseffects on survival over a 15-year period // N. Engl. J. Med. - 1996. - Vol. 334. - P. 216-219.
Thourani V.H., Weintraub W.S., Stein B. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting // Ann. Thorac. Surg. - 1999. - Vol. 67. - P. 1045-1052.
Lytle B.W., Blackstone E.H,. Loop F.D. Two internal thoracic artery grafts are better than one // J. Thorac. Cardiovasc. Surg. - 1999. - Vol. 117. - P. 855-872.
Taggart D.P., D’Amico R., Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries // Lancet. - 2003. - Vol. 361. - P. 615616.
Buxton B.F., Raman J.S., Ruengsakulrach P. Radial patency and clinical outcomes: five-year interim results of a randomized trial // J. Thorac. Cardiovasc. Surg. - 2003. - Vol. 125. - P. 1363-1371.
Khot U.N., Friedman D.T, Pettersson G. et al. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts // Circulation. - 2004. - Vol. 109. - P. 2086-2091.
Dijk D., Nierich A.P., Jansen E.W. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study // Circulation. - 2002. - Vol. 104. - P. 1761-1766.
Angelini G.D., Taylor F.C., Reeves B.C. et al. Early and mid-term outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1. and 2): a pooled analysis of two randomized controlled trials // Lancet. - 2002. - Vol. 359. - P. 1194-1199.
Parolari A., Alamanni F., Cannata A. Off-pump versus on-pump coronary artery bypass: a meta-analysis of currently available randomized trials // Ann. Thorac. Surg. - 2003. - Vol. 76. - P. 37-40.
Khan N.E., De Souza A., Mister R. et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery // N. Engl. J. Med. - 2004. - Vol. 350. - P. 21-28.
Hannan E.L., Wu C., Smith C.R. et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization // Circulation. - 2007. - Vol. 116. - P. 1145-1152.
Brener S.J., Loop F.D., Lytle B.W. et al. A profile of candidates for repeat myocardial revascularisation: implications for selection of treatment // J. Thorac. Cardiovasc. Surg. - 1997. - Vol. 114. - P. 153-161.
Lytle B.W., Loop F.D., Taylor P.C. et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries // J. Thorac. Cardiovasc. Surg. - 1993. - Vol. 105. - P. 605-612.
Rihal C.S., Raco D.L., Gersh B.J. et al. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations // Circulation. - 2003. - Vol. 108. - P. 2439-2445.
Yusuf S., Zucker D., Peduzzi P. et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration // Lancet. - 1994. - Vol. 344. - P. 563-570.
Jones R.H. Kesler K., Phillips H.R. et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease // J. Thorac. Cardiovasc. Surg. - 1996. - Vol. 111. - P. 1013-1025.
The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial coronary bypass surgery for stable angina // N. Engl. J. Med. - 1984. - Vol. 311. - P. 1333.
Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery // Circulation. - 1985. - Vol. 72. - P. 90.
Passamani E., Davis K.B., Gilliespie M.J. et al. A randomized trial of coronary artery bypass syrgery. Survival of patients with a low ejection fraction // N. Engl. J. Med. - 1985. - Vol. 312. - P. 1665.
European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris // Lancet. - 1982. - Vol. 2. - P. 1173-1180.
Aaa Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial // N. Engl. J. Med. - 1984. - Vol. 310. - P. 750-758.
Davies R.F., Goldberg A.D., Forman S. et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study 2 year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization // Circulation. - 1997. - Vol. 95. - P. 2037-2043.
Pfisterer M.E., Kiowski W., Brunner H. et al. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction // Circulation. - 1993. - Vol. 87. - P. 309-311.
Hueb W.A., Bellotti G., de Oliveira S.A. et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses // J. Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 1600-1605.
Cameron A.A., Davis K.B., Rogers W.J. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study // J. Am. Coll. Cardiol. - 1995. - Vol. 26. - P. 895-599.
Bell M.R., Gersh B.J., Schaff H.V. Effect of completeness of revascularisation on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry // Circulation. - 1992. - Vol. 86. - P. 446-457.
Pocock S.J., Henderson R.A., Rickards A.F. et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery // Lancet. - 1995. - Vol. 346. - P. 1184-1149.
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease // N. Engl. J. Med. - 1996. -
Vol. 335. - P. 217-225.
Daemen J., Boersma E., Flather M. et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials // Circulation. - 2008. - Vol. 118. - P. 1146-1154.
Mercado N., Wijns W., Serruys P.W. et al. One-year outcomes of CABG surgery versus PCI with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomised clinical trials // J. Thorac. Cardiovasc. Surg. - 2005. - Vol. 130. - P. 512-519.
Hoffman S.N., TenBrook J.A., Wolf M.P. et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: oneto 8 year outcomes // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 1293-1304.
Hamm C.W., Reimers J., Ischinger T. et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) // N. Engl. J. Med. - 1994. - Vol. 331. - P. 1037-1043.
Hannan E.L., Racz M.J., Walford G. et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation // N. Engl. J. Med. - 2005. - Vol. 352. - P. 2174-2183.
Hannan E.L., Wu C., Walford G. et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease // N. Engl. J. Med. - 2008. - Vol. 358. - P. 331-341.
Scheen A.J., Warzee F., Legrand V.M. Drug-eluting stents: meta-analysis in diabetic patients // Eur. Heart J. - 2004. - Vol. 25. - P. 2167-2168.
Legrand V.M., Serruys P.W., Unger F. et al. Arterial Revascularization Therapy Study (ARTS) Investigators. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease // Circulation. - 2004. - Vol. 109. - P. 1114-1120.
Serruys P.W., Ong A.T., Morice M.C. et al. On behalf of the ARTS II Investigators. Arterial Revascularization Therapies Study Part II: Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. Eurointervention. - 2005. - Vol. 2. - P. 147-156.
Fasseas P., Orford J.L., Panetta C.J. et al. Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16298. procedures // Am. Heart J. - 2004. - Vol. 147. - P. 140-145.
Rubartelli P., Verna E., Niccoli L. et al. Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: six-year clinical follow-up of the GISSOC trial // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 1488-1492.
Werner G.S., Krack A., Schwarz G. et al. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 2301-2306.
Serruys P.W., Morice M.C., Kappetein P. et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease // N. Engl. J. Med. - 2009. - Vol. 360. - P. 961972.
Mannheimer C., Camici P., Chester M.R. et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina // Eur. Heart J. - 2002. - Vol. 23. - P. 355370.
Lanza G.A. Alternative treatments for angina // Heart. - 2007. - Vol. 93. - P. 544-546.
TenVaarwerk A.M., Jessurun G.A.J., DeJongste M.J.L. et al. Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris // Heart. - 1999. - Vol. 82. - P. 82-88.
Di Pede F., Lanza G.A., Zuin G. et al. Spinal cord stimulation for refractory angina pectoris patients: data on clinical outcome from the prospective Italian registry // Am. J. Cardiol. - 2003. - Vol. 91. - P. 951-955.
Ekre O., Norsell H., Währborg P. et al. Spinal cord stimulation and coronary artery bypass grafting provide equal improvement in quality of life. Data from the ESBY study // Eur. Heart J. - 2002. - Vol. 23. - P. 1938-1945.
Arora R.R., Chou T.M., Jain D. et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes // J. Am. Coll. Cardiol. - 1999. - Vol. 33. - P. 1833-1840.
Loh P.H., Cleland J.G., Louis AA, et al. Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry // Clin. Cardiol. - 2008. - Vol. 31. - P. 159-164.
Soran O., Kennard E.D., Kfoury A.G. et al., for the IEPR Investigators. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfubction (report from the International EECP Patient Registry) // Am. J. Cardiol. - 2006. - Vol. 97. - P. 17-20.
Saririan M., Eisenberg M.J. Myocardial laser revascularization for the treatment of end-stage coronary artery disease // J. Am. Coll. Cardiol. - 2003. - Vol. 41. - P. 173-183.
Leon M.B., Kornowski R., Downey W.E. et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease // J. Am. Coll. Cardiol. - 2005. - Vol. 46. - P. 1812-1819.
Grines C.L., Watkins M.W., Helmer G. et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris // Circulation. - 2002. - Vol. 105. - P. 1291-1297.
Kastrup J., Jorgensen E., Ruck A. et al. Euroinject One Group. Direct intramyocardial plasmid vascular endothelial growth factor-A165. gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial // J. Am. Coll. Cardiol. - 2005. - Vol. 45. - P. 982-988.
Lanza G.A. Cardiac syndrome X: a critical overview and future perspectives // Heart. - 2007. - Vol. 93. - P. 159-166.
Bottcher M., Botker H.E., Sonne H. et al. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X // Circulation. - 1999. - Vol. 99. - P. 1795-1801.
Panting J.R., Gatehouse P.D., Yang G.Z. et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging // N. Engl. J. Med. - 2002. - Vol. 346. -
P. 1948-1953.
Egashira K., Inou T., Hirooka Y. et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms // N. Engl. J. Med. - 1993. - Vol. 328. - P. 1659-1664.
Rosen S.D., Paulesu E., Wise R.J.S. et al. Central neural contribution to the perception of chest pain in cardiac syndrome X // Heart. - 2002. - Vol. 87. - P. 513-519.
Pasceri V., Lanza G.A., Buffon A. et al. Role of abnormal pain sensitivity and behavioural factors in determining chest pain in syndrome X // J. Am. Coll. Cardiol. - 1998. - Vol. 31. - P. 62-66.
Lanza G.A., Giordano A.G., Pristipino C. et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy // Circulation. - 1997. - Vol. 96. - P. 821-826.